Dual diagnosis: the diagnosis and treatment of depression with co-existing substance misuse

by Dr Roger Bloor and Professor Ilana Crome

 

Published: April 2006

 

The prevalence of co-existing substance misuse and psychiatric disorder (dual diagnosis, comorbidity) has increased over the past decade, and the indications are that it will continue to rise.

 

In recent years there have been unprecedented developments in the pharmacological treatment of alcohol, opiate and nicotine misuse. Here we evaluate the evidence on the use of some of these treatments in dual diagnosis (with psychotic, mood and anxiety disorders). The evidence base is limited by the exclusion of mental illness when pharmacological agents for substance misuse are evaluated and vice versa.

 

We set the available information within the context of the psychosocial management of comorbid substance misuse and mental illness, and the framework for service delivery recommended by UK national policy.

 

The module will take you through some of the key points with regard to:

 

  • terminology
  • prevalence
  • assessment
  • treatment.

 

Start the module

 

 

If you like this module, you may also be interested in:

 

Stimulants: epidemiology and impact on mental health by Professor Fabrizio Schifano and Dr Antonio Albanese

 

Substance misuse in older people by Dr Rahul Rao and Professor Ilana Crome

 

Treating depression in later life by Professor Robert Baldwin, Dr Deepak K Sachdeva and Dr Amit Nulkar

 

 

BJPysch Advances: related articles for CPD Online

 

 

Related Advances articles

 

Download take-home notes to print and annotateDownload take-home notes to print and annotate

© 2018 Royal College of Psychiatrists